“The CreditWatch placement reflects our receipt of CHI’s fiscal year-end statements and commentary, which combined with other non-financial factors is reflective of continued ongoing financial and operational problems,” said S&P analyst Martin Arrick. “While some progress has been made on CHI’s improvement plan, some slippage is also evident.”
CHI reported an operating loss of $483.3 million in fiscal year 2016, Last year, the health system maintained an operating surplus of $23.9 million.
More articles on healthcare finance:
NY hospital continues to fight $1.6M Medicare ‘clawback’
Henry Ford director says payments aren’t truly bundled under BPCI initiative
Mayo Clinic raises prices at Wisconsin hospitals to offset uncompensated care costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
